A small trial in individuals with type 1 diabetes and gastroparesis found that hybrid closed loop insulin pump therapy improved the mean percentage time that blood glucose was in range (3.9–10 mmol/l) from 26% to 58.4%, however neither gastrointestinal symptoms nor gastric emptying were evaluated [67]. This evidence concerns the gene INS and type 1 diabetes mellitus.